Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computational Analysis of ELOVL6 Structure and Inhibition for Rational Drug Design.

Journal of chemical information and modeling·2026
Same author

Disrupting the feed-forward cycle of RyR1 Ca<sup>2+</sup> leak and oxidative stress mitigates doxorubicin-induced skeletal myopathy.

American journal of physiology. Cell physiology·2026
Same author

Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA group.

Bone marrow transplantation·2026
Same author

Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder.

American journal of human genetics·2026
Same author

Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1.

American journal of human genetics·2026
Same author

Mitochondria and Lipid Defects in Hereditary Progranulin-Related Frontotemporal Dementia.

Cells·2026

Related Experiment Video

Updated: Jun 27, 2026

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

Gene expression profiling in limb-girdle muscular dystrophy 2A.

Amets Sáenz1, Margarita Azpitarte, Rubén Armañanzas

  • 1Experimental Unit, Hospital Donostia, Donostia-San Sebastián, Basque Country, Spain. amets.saenzpena@osakidetza.net

Plos One
|November 19, 2008
PubMed
Summary

Limb-girdle muscular dystrophy type 2A (LGMD2A) gene expression profiling reveals altered pathways in muscle development and degradation. This study identifies potential therapeutic targets for LGMD2A by examining calpain 3 (CAPN3) dysfunction.

More Related Videos

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Related Experiment Videos

Last Updated: Jun 27, 2026

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Area of Science:

  • Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • Limb-girdle muscular dystrophy type 2A (LGMD2A) is a genetic disorder caused by mutations in calpain 3 (CAPN3).
  • The precise functions and in vivo substrates of calpain 3 in muscle cells remain largely unknown.
  • Understanding gene expression alterations in LGMD2A is crucial for identifying therapeutic targets.

Purpose of the Study:

  • To identify genes with altered expression in LGMD2A patients.
  • To investigate the pathways implicated by these gene expression changes.
  • To explore the role of calpain 3 (CAPN3) in skeletal muscle development and disease.

Main Methods:

  • Gene expression profiling using array technology.
  • Comparison of gene expression between ten LGMD2A patient muscle samples and ten normal muscle samples.
  • Molecular diagnosis was ascertained for all patient samples.

Main Results:

  • Upregulation of genes involved in extracellular matrix, cell adhesion, muscle development, and signal transduction.
  • Deregulation of genes in the ubiquitin proteasome degradation pathway.
  • Downregulation of key transcription factor genes (MYC, FOS, EGR1) and upregulation of IL-32 and immunoglobulin genes.

Conclusions:

  • Proteins in the costameric region are likely regulated by calpain 3 (CAPN3) during skeletal muscle development.
  • Calpain 3 activity may control the ubiquitin proteasome degradation pathway.
  • Altered Wnt signaling and inflammation may contribute to LGMD2A pathogenesis, suggesting novel therapeutic avenues.